Product Goldstream Star Manager Series》 

 

Global Healthcare Hedge Fund 

Interested clients can download “Goldstream Connect” to include this index into their portfolios or contact our client service team

Fund Highlights

  • Industry focus: healthcare is an industry with robust demand and sustainable long-term growth, and an industry with  many attractive investment targets

  • Fundamental-driven strategy: more than 500 healthcare names under coverage; identify and invest in high-quality companies via solid fundamental research;

  • Market diversification: cover three major markets (A share, H share, and the US) to broaden opportunities; and hedge risks as well as create synergy.

 
 

Fund Manager:Victor Li 

  • Portfolio Manager joined Hony Capital in 2012, focusing on healthcare investment. He previously worked at Snow Lake Capital (Hedge Fund), Goldman Sachs, and Decision Resources Inc., with more than 12 years’ healthcare market research and investment experience across different markets. He has BS in Biology from Peking University, Ph.D. in Biochemistry from Boston University, and MBA from Harvard Business School.

Fund Performance 

 

  Fund performance is restricted to investors only  

  • If you are an investor to this product, please try to download Goldstream Connect and access the fund information there. 

  • If you are a potential investor and would like to find out more about this product, please contact our client relations head Andrew Yin.

 

 

Fund Statistics

   Fund statistics are restricted to investors only  

  • If you are an investor to this product, please try to download Goldstream Connect and access the fund information there. 

  • If you are a potential investor and would like to find out more about this product, please contact our client relations head Andrew Yin.

 

Strategy Description

  • Healthcare industry focus: establish global coverage across three major markets (A share, H share and US); and invest in three major categories: large companies with sustainable growth and fair entry price; subsector leaders with strong growth momentum and high TAM (total addressable market); and early-stage biotech with proprietary breakthrough technology

  • Value-investing philosophy: bottom-up research and stock-picking; establish research edge on core therapeutic areas and companies, via in-depth fundamental analysis (product, pipeline, and channel capability assessment; financial results tracking; and corporate governance and management quality evaluation)

  • Portfolio construction and risk management: long-biased L/S strategy (net exposure at -25% to 75%), and relatively concentrated portfolio (~40 positions). Dual-layer risk control by both PM and platform risk management department; the platform will automatically perform risk execution when the limit is breached.

 

地址:中环交易广场第一座27楼2701室 电话:+852 3961 9700  传真:+852 3961 9799

业务及投资者关系主管,邮箱:andrewyin@goldstreamfund.com

© COPYRIGHT 2018 金涌投资